CytomX Therapeutics (CTMX) EBITDA (2014 - 2026)
CytomX Therapeutics (CTMX) reported EBITDA of -$23.73 million for Q2 2026, compared with -$939,000 a year earlier.
Powered by 
Analysis
CytomX Therapeutics (CTMX) EBITDA (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CytomX Therapeutics' EBITDA came in at -$86.21 million; for FY2025, it was -$20.99 million.
- By year, EBITDA came in at $26.76 million in FY2024, -$4.31 million in FY2023, -$98.89 million in FY2022 and -$113.34 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$34.23 million in Q4 2021 and a high of $23.01 million in Q1 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$19.42 million (Q1 2026), -$27.42 million (Q4 2025) and -$15.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | -23.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.73 Mn |
| Mar 31, 2026 | -19.42 Mn |
| Dec 31, 2025 | -27.42 Mn |
| Sep 30, 2025 | -15.63 Mn |
| Jun 30, 2025 | -939,000.00 |
| Mar 31, 2025 | 23.01 Mn |
| Dec 31, 2024 | 18.09 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Mar 31, 2024 | 12.12 Mn |
| Dec 31, 2023 | -120,000.00 |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | -2.74 Mn |
| Mar 31, 2023 | -5.06 Mn |
| Dec 31, 2022 | -8.90 Mn |
| Sep 30, 2022 | -29.09 Mn |
| Jun 30, 2022 | -29.44 Mn |
| Mar 31, 2022 | -31.46 Mn |
| Dec 31, 2021 | -34.23 Mn |
| Sep 30, 2021 | -30.36 Mn |
API Access
CytomX Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();